Literature DB >> 16950693

Regression of nodular liver lesions in Wilson's disease.

D Kozic1, M Svetel, I Petrovic, R N Sener, V S Kostic.   

Abstract

Long-term follow-up abdominal imaging studies have not been reported previously in patients with the hepatic form of Wilson's disease (WD). This paper reports the case of a 35-year-old woman with symptoms dating back several months and with multiple, nodular liver lesions. The lesions were hyperdense on non-enhanced computed tomography and hypointense on T2-weighted magnetic resonance (MR) images. A diagnosis of WD was established several weeks after her admission to hospital, and chelating treatment was commenced promptly. No abnormalities were found on follow-up MR examinations of the abdomen and brain 4.5 years later. These imaging features suggest that so long as WD is diagnosed in the initial stages, liver nodules can regress with time and complete healing can be achieved with continuous decoppering treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16950693     DOI: 10.1080/02841850600702176

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  3 in total

1.  MR imaging features of liver involvement by Wilson disease in adult patients.

Authors:  Ottavia Vargas; Sid Ahmed Faraoun; Raphael Dautry; Youcef Guerrache; France Woimant; Lounis Hamzi; Mourad Boudiaf; Aurelia Poujois; Philippe Soyer; Anthony Dohan
Journal:  Radiol Med       Date:  2016-04-22       Impact factor: 3.469

2.  Clinical application of liver MR imaging in Wilson's disease.

Authors:  Jung-Eun Cheon; In-One Kim; Jeong Kee Seo; Jae Sung Ko; Jeong Min Lee; Cheong-Il Shin; Woo Sun Kim; Kyung Mo Yeon
Journal:  Korean J Radiol       Date:  2010-10-29       Impact factor: 3.500

3.  Reversible lesions in the brain parenchyma in Wilson's disease confirmed by magnetic resonance imaging: earlier administration of chelating therapy can reduce the damage to the brain.

Authors:  Duško B Kozić; Igor Petrović; Marina Svetel; Tatjana Pekmezović; Aleksandar Ragaji; Vladimir S Kostić
Journal:  Neural Regen Res       Date:  2014-11-01       Impact factor: 5.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.